OBALON THERAPEUTICS, INC. (NASDAQ:OBLN) Files An 8-K Results of Operations and Financial Condition
Item 2.02.
|
Results of Operations and Financial Condition.
|
reported its financial results for the quarter and year ended
December 31, 2016. A copy of the press release issued by the
Company is furnished as Exhibit 99.1 to this report.
including Exhibit 99.1, shall not be deemed filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended
(the Exchange Act), or otherwise subject to the liabilities of
that section, nor shall it be deemed incorporated by reference
into any other filing under the Exchange Act or under the
Securities Act of 1933, as amended, except as expressly set forth
by specific reference in such a filing.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
|
Exhibit Number
|
Description
|
|
|
99.1
|
Press release dated February 23, 2017.
|
|
About OBALON THERAPEUTICS, INC. (NASDAQ:OBLN)
Obalon Therapeutics, Inc. is a United States-based commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company’s product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients. The Obalon balloon system is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed six months after the first balloon is placed. The Obalon balloon system intends to provide patients and physicians with a reversible and repeatable weight loss solution in an outpatient setting, without altering patient anatomy or requiring surgery. The Company has received Premarket approval (PMA) for its Obalon balloon system based on the results of its United States pivotal clinical trial, referred to as the SMART trial. OBALON THERAPEUTICS, INC. (NASDAQ:OBLN) Recent Trading Information
OBALON THERAPEUTICS, INC. (NASDAQ:OBLN) closed its last trading session 00.00 at 9.24 with 59,173 shares trading hands.